STOCKSCREENR

0JDI.L

LSE

Ionis Pharmaceuticals, Inc.

$75.24+1.54(+2.08%)Mkt Cap: $12.15B

Key Stats

Market Cap

$12.15B

P/E Ratio

-2687.00

EPS

$-0.03

Dividend Yield

0.00%

52-Week Range

$33.21 — $77.14

Volume

240.16K

Avg Volume

351

Beta

0.40

Price Alerts for 0JDI.L

Get alerted when 0JDI.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-2687.00

Forward P/E

—

PEG Ratio

0.70

P/S (TTM)

13.45

P/B (TTM)

25.44

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.69%

ROA (TTM)

-0.11%

ROIC

—

Gross Margin

0.98%

Operating Margin

-0.41%

Net Margin

—

Debt/Equity

5.35

Current Ratio

3.83

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-3.01%

EPS Growth (5Y)

-2.12%

Sales Growth (3Y)

-0.01%

Sales Growth (5Y)

-0.06%

EPS Est (This Year)

$-3.14

EPS Est (Next Year)

$-1.20

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$16.53

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

158.91M

Float

160.57M

Free Float %

101.04%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

LSE

IPO Date

2018-01-29

Employees

1069

CEO

Brett Monia

Index Membership

—

Website

https://www.ionispharma.com

Ionis Pharmaceuticals, Inc. (0JDI.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $12.15B, a P/E ratio of -2687.00, 0JDI.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0JDI.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0M3Q.L

Zoetis Inc.

$115.60

+1.72%

$55.54B

0J2O.L

Halozyme Therapeutics, Inc.

$64.11

+1.60%

$7.57B

0HD2.L

Alnylam Pharmaceuticals, Inc.

$310.82

+4.76%

$41.22B

0RD1.L

Camurus AB (publ)

$530.55

+0.06%

$31.64B

0JAV.L

Insmed Incorporated

$136.55

+1.81%

$29.44B

0JDM.L

IQVIA Holdings Inc.

$158.90

+1.74%

$26.97B

Frequently Asked Questions

What is Ionis Pharmaceuticals, Inc.'s P/E ratio?

Ionis Pharmaceuticals, Inc. (0JDI.L) has a trailing twelve-month (TTM) P/E ratio of -2687.00. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Ionis Pharmaceuticals, Inc. pay a dividend?

No, Ionis Pharmaceuticals, Inc. (0JDI.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Ionis Pharmaceuticals, Inc.'s market cap?

Ionis Pharmaceuticals, Inc. (0JDI.L) has a market capitalization of $12.15 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.